Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 05, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | -- | -- | |
| Aug 05, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | -- | -- | |
| Aug 05, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | -- | -- | |
| Aug 05, 2015 | SVP and General Counsel | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,800 | -- | -- | |
| Jul 16, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,000 | -- | -- | |
| Jun 08, 2015 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,649 | -- | -- | |
| Feb 13, 2015 | SVP, GM - Oncology | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,100 | -- | -- | |
| Nov 10, 2014 | SVP and General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| Nov 10, 2014 | SVP and General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| Nov 10, 2014 | SVP and General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.